XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.1
Purchase Price Allocation (Tables)
12 Months Ended
Dec. 31, 2023
Purchase Price Allocation  
Schedule of Total Purchase Price

The total purchase price and allocated purchase price is summarized as follows:

 

Number of shares of common stock of the combined company owned by the Company’s stockholders immediately prior to the merger (1)   3,860,898 
Multiplied by the fair value per share of common stock (2)  $2.57 
Fair value of the Company’s pre-Merger common stock   9,928,262 
      
Number of shares of Series D Preferred Stock issued to effectuate the Merger   4,423 
Multiplied by the fair value per share (3)  $725.57 
Fair value of Series D Preferred Stock issued as consideration   3,209,196 
      
Prairie LLC Transaction costs (4)   2,032,696 
Purchase price  $15,170,154 

 

 

 

  (1) Represents the historical shares of the common stock outstanding immediately prior to the Closing of the Merger on May 3, 2023.
     
  (2) Based on the last reported sale price of the common stock on OTC Capital Markets on May 3, 2023, the closing date of the Merger (the “Closing Date”).
     
  (3) Fair value calculated as described above on May 3, 2023.
     
  (4) Prairie LLC transaction costs consist primarily of legal expenses incurred by Prairie LLC. The transaction costs have been reflected as an increase in the purchase price.
Schedule of Allocation of Purchase Price to Net Assets Acquired

 

Purchase Price Allocation:  May 3, 2023 
Cash and cash equivalents  $42,360 
Accounts receivable   8,014 
Prepaid expenses   63,795 
Mining equipment (1)   18,140,874 
Deposits on mining equipment   2,928,138 
Accounts payable and accrued expenses   (3,352,389)
Secured convertible debentures   (1,981,000)
SBA loan payable   (150,000)
Share issuance liability   (529,638)
Net assets acquired  $15,170,154 

 

 

 

(1) In accordance with GAAP for asset acquisitions, the excess purchase price over the fair value of the acquired assets and liabilities was ascribed to the property and equipment acquired. See Note 4 for additional discussion of the subsequent impairment recognized.